Folgen
EMANUELE MONTOMOLI
EMANUELE MONTOMOLI
Bestätigte E-Mail-Adresse bei unisi.it
Titel
Zitiert von
Zitiert von
Jahr
Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza
N Landry, BJ Ward, S Trépanier, E Montomoli, M Dargis, G Lapini, ...
PloS one 5 (12), e15559, 2010
3382010
A clinical trial of a whole-virus H5N1 vaccine derived from cell culture
HJ Ehrlich, M Müller, HML Oh, PA Tambyah, C Joukhadar, E Montomoli, ...
New England Journal of Medicine 358 (24), 2573-2584, 2008
3092008
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2
SS Ahmed, W Volkmuth, J Duca, L Corti, M Pallaoro, A Pezzicoli, A Karle, ...
Science translational medicine 7 (294), 294ra105-294ra105, 2015
3022015
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine
G Galli, K Hancock, K Hoschler, J DeVos, M Praus, M Bardelli, C Malzone, ...
Proceedings of the National Academy of Sciences 106 (19), 7962-7967, 2009
2972009
SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma
E Andreano, G Piccini, D Licastro, L Casalino, NV Johnson, I Paciello, ...
BioRxiv, 2020
2812020
Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice
A Wack, BC Baudner, AK Hilbert, I Manini, S Nuti, S Tavarini, H Scheffczik, ...
Vaccine 26 (4), 552-561, 2008
2462008
MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults
A Banzhoff, R Gasparini, F Laghi-Pasini, T Staniscia, P Durando, ...
PloS one 4 (2), e4384, 2009
2212009
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma
E Andreano, G Piccini, D Licastro, L Casalino, NV Johnson, I Paciello, ...
Proceedings of the National Academy of Sciences 118 (36), e2103154118, 2021
2202021
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
E Andreano, E Nicastri, I Paciello, P Pileri, N Manganaro, G Piccini, ...
Cell 184 (7), 1821-1835. e16, 2021
2132021
Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy
G Apolone, E Montomoli, A Manenti, M Boeri, F Sabia, I Hyseni, L Mazzini, ...
Tumori Journal 107 (5), 446-451, 2021
1992021
Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples
A Manenti, M Maggetti, E Casa, D Martinuzzi, A Torelli, CM Trombetta, ...
Journal of medical virology 92 (10), 2096-2104, 2020
1902020
Cross-protection by MF59™-adjuvanted influenza vaccine: Neutralizing and haemagglutination-inhibiting antibody activity against A (H3N2) drifted influenza viruses
F Ansaldi, S Bacilieri, P Durando, L Sticchi, L Valle, E Montomoli, G Icardi, ...
Vaccine 26 (12), 1525-1529, 2008
1542008
Epidemiology and prevention of Human Papillomavirus
I Manini, E Montomoli
Ann Ig 30 (4), 28-32, 2018
1512018
Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants
E Andreano, I Paciello, G Piccini, N Manganaro, P Pileri, I Hyseni, ...
Nature 600 (7889), 530-535, 2021
1492021
Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects
R Gasparini, T Pozzi, E Montomoli, E Fragapane, F Senatore, M Minutello, ...
European journal of epidemiology 17, 135-140, 2001
1422001
Current adjuvants and new perspectives in vaccine formulation
E Montomoli, S Piccirella, B Khadang, E Mennitto, R Camerini, A De Rosa
Expert review of vaccines 10 (7), 1053-1061, 2011
1342011
Influenza immunology evaluation and correlates of protection: a focus on vaccines
CM Trombetta, E Montomoli
Expert review of vaccines 15 (8), 967-976, 2016
1272016
Overview of serological techniques for influenza vaccine evaluation: past, present and future
CM Trombetta, D Perini, S Mather, N Temperton, E Montomoli
Vaccines 2 (4), 707-734, 2014
1182014
Antibody response against heterogeneous circulating influenza virus strains elicited by MF59-and non-adjuvanted vaccines during seasons with good or partial matching between …
F Ansaldi, M Zancolli, P Durando, E Montomoli, L Sticchi, G Del Giudice, ...
Vaccine 28 (25), 4123-4129, 2010
1062010
Water and air ozone treatment as an alternative sanitizing technology
M Martinelli, F Giovannangeli, S Rotunno, CM Trombetta, E Montomoli
Journal of preventive medicine and hygiene 58 (1), E48, 2017
1032017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20